Recombinant Bifidobacterium longum subsp. infantis tRNA dimethylallyltransferase (miaA)

What is the function of tRNA dimethylallyltransferase (miaA) in Bifidobacterium longum subsp. infantis?

The miaA gene in B. longum subsp. infantis encodes tRNA (adenosine(37)-N6)-dimethylallyltransferase, which catalyzes the first step in post-transcriptional modification of adenosine at position 37 (A37) in tRNAs that read codons beginning with U (except tRNA-Met). This enzyme transfers a dimethylallyl group from dimethylallyl pyrophosphate to the N6 position of A37, forming N6-isopentenyladenosine (i6A37) .

Based on studies in other bacterial genera such as Streptomyces, this modification significantly enhances codon-anticodon interactions during translation, particularly for rare codons like UUA . In B. longum subsp. infantis, which has evolved specifically for the infant gut environment, this translation efficiency is likely crucial for metabolic adaptation and host interactions.

To properly characterize miaA function in B. longum subsp. infantis, researchers should:

• Generate miaA knockout mutants using CRISPR-Cas9 or homologous recombination

• Perform comparative proteomics between wild-type and mutant strains

• Analyze translation efficiency through ribosome profiling

• Assess phenotypic changes in growth, metabolism, and stress response

How is the miaA gene organized in B. longum subsp. infantis genome?

The miaA gene in B. longum subsp. infantis is typically organized as a single open reading frame containing the following key structural features:

For accurate gene structure determination, researchers should employ:

• Genome sequence analysis with bioinformatics tools

• PCR amplification with sequence-specific primers

• Promoter analysis using reporter systems

• 5' RACE to determine transcription start sites

How does miaA expression vary across different growth phases in B. longum subsp. infantis?

miaA expression in B. longum subsp. infantis likely follows growth phase-dependent patterns similar to other translation-related genes. To characterize this expression profile, researchers should employ:

• Quantitative RT-PCR with specific primers targeting miaA

• Reporter gene fusions (e.g., miaA promoter-gfp constructs)

• Western blot analysis with anti-MiaA antibodies

• RNA-Seq for transcriptome-wide context

A typical expression pattern might resemble:

Experimental design should include:

• Synchronized cultures for consistent growth phase assessment

• Multiple biological and technical replicates

• Normalization to stable reference genes

• Statistical analysis to confirm significance of expression changes

What transcription factors regulate miaA expression in Bifidobacterium?

While specific data on transcription factors regulating miaA in B. longum subsp. infantis is limited, several approaches can be used to identify these regulatory proteins:

• In silico promoter analysis to identify putative transcription factor binding sites

• Electrophoretic mobility shift assays (EMSA) with miaA promoter fragments

• Chromatin immunoprecipitation (ChIP) adapted for Bifidobacterium

• Reporter systems with promoter truncations and mutations

Likely candidates for miaA regulation include:

• Global translational regulators responding to nutrient availability

• Stress-responsive transcription factors

• Growth phase-dependent regulators

Experimental validation of these regulators would involve gene deletion studies and complementation experiments to confirm direct regulatory relationships.

What expression systems are most effective for recombinant production of B. longum subsp. infantis miaA?

For heterologous expression of B. longum subsp. infantis miaA, several expression systems can be employed:

To optimize expression, researchers should consider:

• Codon optimization for the host organism

• Fusion tags for improved solubility (MBP, SUMO, Thioredoxin)

• Co-expression with chaperones for proper folding

• Signal peptides for secretion when appropriate

Enzyme activity should be verified using synthetic tRNA substrates and analyzed by mass spectrometry to detect modified nucleosides.

What purification strategies yield the highest activity of recombinant miaA?

Obtaining pure, active recombinant miaA requires careful consideration of purification conditions:

• Affinity chromatography options:

  • His-tagged miaA purified on Ni-NTA columns

  • GST-fusion proteins on glutathione sepharose

  • MBP-fusion proteins on amylose resin

• Optimal buffer conditions:

  • pH 7.5-8.0 phosphate or Tris buffer

  • 150-300 mM NaCl to maintain solubility

  • 5-10% glycerol as stabilizer

  • 1-5 mM DTT or β-mercaptoethanol to protect cysteine residues

  • Protease inhibitors during initial extraction

• Additional purification steps:

  • Ion exchange chromatography (typically Q-sepharose)

  • Size exclusion chromatography for final polishing

  • Removal of affinity tags using specific proteases

Activity retention during purification can be monitored by:

• In vitro activity assays with synthetic tRNA substrates

• Thermal shift assays to verify proper folding

• Dynamic light scattering to confirm monodispersity

Typical yields range from 5-15 mg/L in E. coli systems and 0.5-2 mg/L in Bifidobacterium systems.

How can researchers measure miaA enzyme activity accurately in vitro?

Accurate measurement of miaA enzyme activity requires specialized assays that can detect the transfer of dimethylallyl groups to tRNA substrates:

• Radiometric assays:

  • Using [14C] or [3H]-labeled dimethylallyl pyrophosphate

  • Measurement of labeled tRNA by scintillation counting

  • Filter binding assays to separate substrate from product

• HPLC-based methods:

  • Nucleoside analysis after enzymatic hydrolysis of tRNA

  • Reverse-phase HPLC with UV detection at 254 nm

  • Comparison with standard nucleoside modifications

• Mass spectrometry approaches:

  • LC-MS/MS analysis of modified nucleosides

  • Detection of mass shift (+68 Da) for dimethylallyl addition

  • Monitoring multiple reaction transitions for quantification

• Fluorescence-based assays:

  • Fluorescently labeled tRNA substrates

  • FRET-based detection of conformational changes upon modification

  • High-throughput adaptations for screening studies

A typical reaction mixture would contain:

• Purified recombinant miaA (0.1-1 μM)

• tRNA substrate (1-10 μM)

• Dimethylallyl pyrophosphate (50-200 μM)

• MgCl2 (5-10 mM)

• Buffer (50 mM Tris-HCl, pH 7.5)

• Reducing agent (1-5 mM DTT)

Kinetic parameters should be determined by varying substrate concentrations and analyzing data using Michaelis-Menten or Lineweaver-Burk plots.

What are the critical residues for catalytic activity in B. longum subsp. infantis miaA?

Identifying critical catalytic residues in miaA requires a combination of structural, computational, and experimental approaches:

• Structure-based methods:

  • Homology modeling based on known miaA structures

  • Molecular docking of substrates

  • Molecular dynamics simulations

• Sequence conservation analysis:

  • Multiple sequence alignment across bacterial miaA enzymes

  • Identification of invariant residues across diverse species

  • Evolutionary trace analysis

• Experimental validation:

  • Site-directed mutagenesis of predicted catalytic residues

  • Activity assays of mutant enzymes

  • Complementation studies in miaA-deficient strains

Based on studies of related enzymes, key residues likely include:

• Conserved aspartate residues for metal coordination

• Aromatic residues for tRNA binding

• Basic residues for pyrophosphate interaction

• Hydrophobic residues forming the dimethylallyl binding pocket

Crystal structure determination of B. longum subsp. infantis miaA would provide definitive identification of these critical residues.

How does miaA knockout affect the metabolomic profile of B. longum subsp. infantis?

Deletion of miaA in B. longum subsp. infantis would likely cause significant changes in the metabolomic profile due to altered translation efficiency. To characterize these changes, researchers should employ:

• Sample preparation:

  • Synchronized culture growth

  • Rapid quenching of metabolism

  • Optimized extraction protocols for different metabolite classes

• Analytical techniques:

  • CE-FTMS for comprehensive coverage

  • LC-MS/MS for polar metabolites

  • GC-MS for volatile compounds

  • NMR for structural confirmation

Based on studies of Bifidobacterium metabolism , expected changes might include:

The study should include multiple biological replicates and appropriate statistical analysis (e.g., PCA, PLS-DA) to identify significantly altered metabolites and affected pathways.

How does miaA function affect B. longum subsp. infantis colonization in the gut microbiome?

The impact of miaA on B. longum subsp. infantis colonization in the gut represents a key area for investigation. Methodologies to study this include:

• Animal models:

  • Gnotobiotic mice with defined microbiota

  • Neonatal animal models mimicking infant gut conditions

  • Competitive colonization assays with wild-type and miaA mutant strains

• In vitro models:

  • Intestinal epithelial cell adhesion assays

  • Gut-on-chip microfluidic systems

  • Mucus binding assays

• Analysis techniques:

  • Strain-specific qPCR for quantification

  • 16S rRNA sequencing for community context

  • Fluorescence in situ hybridization for spatial distribution

  • Transcriptomics under gut-simulating conditions

Since miaA affects translation efficiency, particularly of rare UUA codons , colonization may be impacted through:

• Altered expression of adhesins and surface proteins

• Changed metabolism of host-derived glycans

• Reduced stress tolerance in the gut environment

• Modified production of metabolites that affect other microbiome members

Understanding these relationships could provide insights into translational regulation of gut adaptation and inform probiotic development strategies.

How can miaA be leveraged as a tool for controlling gene expression in Bifidobacterium?

The unique properties of miaA and its role in translation efficiency make it a potential tool for controlling gene expression in Bifidobacterium:

• Codon optimization strategies:

  • Enrichment of UUA codons in target genes to make them miaA-dependent

  • Generation of synthetic regulatory circuits based on UUA frequency

  • Creation of inducible systems coupled to miaA expression levels

• Engineering approaches:

  • Development of miaA variants with altered substrate specificity

  • Temperature-sensitive miaA mutants for conditional expression

  • Fusion of miaA to regulatory domains for controlled activity

• Applications:

  • Controlled expression of heterologous proteins

  • Metabolic engineering of probiotic strains

  • Synthetic biology tools for Bifidobacterium

• Validation methods:

  • Reporter gene assays using UUA-enriched GFP variants

  • Proteomic analysis to verify translation control

  • Metabolomic analysis to confirm pathway modulation

These approaches could enable precise control over gene expression without introducing foreign regulatory elements, potentially avoiding regulatory concerns for probiotic applications.

What is the relationship between miaA activity and the production of beneficial metabolites in B. longum subsp. infantis?

The relationship between miaA activity and beneficial metabolite production represents a frontier in understanding how tRNA modification influences probiotic functionality:

• Experimental approaches:

  • Comparative metabolomics of wild-type vs. miaA mutant strains

  • Integration with transcriptomics and proteomics data

  • In vitro fermentation studies with different carbon sources

  • Co-culture experiments with other gut microbes

• Key metabolite categories potentially affected:

• Mechanistic investigations:

  • Identification of metabolic enzymes with UUA codon enrichment

  • Analysis of regulatory proteins affected by miaA function

  • Investigation of stress responses linked to metabolite production

Studies of Bifidobacterium metabolism have shown that probiotic supplementation increases levels of glutathione-related metabolites and TCA cycle intermediates , suggesting these pathways might be regulated at the translational level and thus potentially affected by miaA function.

How conserved is miaA structure and function across different Bifidobacterium species?

Understanding the evolutionary conservation of miaA provides insights into its fundamental importance in Bifidobacterium biology:

• Bioinformatic approaches:

  • Multiple sequence alignment across Bifidobacterium species

  • Phylogenetic analysis to track evolutionary relationships

  • Calculation of selection pressure metrics (dN/dS ratios)

  • Structural modeling to map conservation onto 3D structure

• Expected conservation patterns:

• Experimental validation approaches:

  • Cross-species complementation studies

  • Comparative biochemical characterization

  • Analysis of substrate specificity differences

The high conservation of miaA across Bifidobacterium species, particularly in the catalytic core, suggests its fundamental importance in translational regulation, while species-specific variations might reflect adaptation to different ecological niches.

How does B. longum subsp. infantis miaA differ from homologous enzymes in other bacterial genera?

Comparative analysis of B. longum subsp. infantis miaA with homologs from other bacteria reveals important insights into its specialized functions:

• Comparative features:

  • Sequence divergence reflecting evolutionary distance

  • Structural adaptations to different tRNA pools

  • Substrate specificity variations

  • Regulatory context differences

• Key differences observed across bacterial phyla:

• Experimental approaches:

  • Heterologous expression of different miaA genes in a common host

  • Cross-species activity assays with various tRNA substrates

  • Chimeric enzyme construction to identify domain-specific functions

Studies of miaA in Streptomyces showed it affects morphological and metabolic differentiation , suggesting that while the basic enzymatic function is conserved, the regulatory networks and physiological impacts vary significantly across bacterial genera.